Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.verified

AVTE

Price:

$2.58

Market Cap:

$74.50M

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.[Read more]

Industry

Biotechnology

IPO Date

2021-06-30

Stock Exchange

NASDAQ

Ticker

AVTE

The Current Ratio as of December 2024 (TTM) for Aerovate Therapeutics, Inc. (AVTE) is 8.78

According to Aerovate Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.78. This represents a change of 21.21% compared to the average of 7.25 of the last 4 quarters.

Aerovate Therapeutics, Inc. (AVTE) Historical Current Ratio (quarterly & annually)

How has AVTE Current Ratio performed in the past?

The mean historical Current Ratio of Aerovate Therapeutics, Inc. over the last ten years is 20.06. The current 8.78 Current Ratio has changed 4.28% with respect to the historical average. Over the past ten years (40 quarters), AVTE's Current Ratio was at its highest in in the December 2021 quarter at 68.37. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

20.06

Median

7.04

Minimum

2.64

Maximum

68.37

Aerovate Therapeutics, Inc. (AVTE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aerovate Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.49%

Maximum Annual Current Ratio = 68.37

Minimum Annual Increase = -75.28%

Minimum Annual Current Ratio = 2.64

Quarterly (TTM)
Annual
YearCurrent RatioChange
20237.04-58.31%
202216.90-75.28%
202168.372.49%
20202.64-50.72%

Aerovate Therapeutics, Inc. (AVTE) Average Current Ratio

How has AVTE Current Ratio performed in the past?

The current Current Ratio of Aerovate Therapeutics, Inc. (AVTE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

30.77

5-year avg

20.06

10-year avg

20.06

Aerovate Therapeutics, Inc. (AVTE) Current Ratio vs. Peers

How is AVTE’s Current Ratio compared to its peers?

Aerovate Therapeutics, Inc.’s Current Ratio is greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (12.75), less than Rezolute, Inc. (13.79), less than AN2 Therapeutics, Inc. (9.75), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Opthea Limited (2.94), greater than Mineralys Therapeutics, Inc. (8.55),

Build a custom stock screener for Aerovate Therapeutics, Inc. (AVTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aerovate Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aerovate Therapeutics, Inc. (AVTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aerovate Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Aerovate Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Aerovate Therapeutics, Inc. (AVTE)?

What is the highest Current Ratio for Aerovate Therapeutics, Inc. (AVTE)?

What is the 3-year average Current Ratio for Aerovate Therapeutics, Inc. (AVTE)?

What is the 5-year average Current Ratio for Aerovate Therapeutics, Inc. (AVTE)?

How does the current Current Ratio for Aerovate Therapeutics, Inc. (AVTE) compare to its historical average?